Intravenous Immunoglobulin for Hemophagocytic Lymphohistiocytosis?
- 15 January 2002
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 20 (2) , 599-601
- https://doi.org/10.1200/jco.2002.20.2.599
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromesAmerican Journal of Hematology, 2001
- Requirement for Etoposide in the Treatment of Epstein-Barr Virus–Associated Hemophagocytic LymphohistiocytosisJournal of Clinical Oncology, 2001
- An Animal Model for Human EBV-Associated Hemophagocytic Syndrome: Herpesvirus Papio Frequently Induces Fatal Lymphoproliferative Disorders with Hemophagocytic Syndrome in RabbitsThe American Journal of Pathology, 2001
- Outcome of Clonal Hemophagocytic Lymphohistiocytosis: Analysis of 32 CasesLeukemia & Lymphoma, 2000
- Treatment Strategies for Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis (EBV-HLH)Leukemia & Lymphoma, 2000
- Prognostic factors of hemophagocytic syndrome in adults: analysis of 34 casesEuropean Journal of Haematology, 1997